Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: Two randomised, placebo-controlled trials.
暂无分享,去创建一个
[1] V. Tremaroli,et al. Glucose‐lowering effects and mechanisms of the bile acid‐sequestering resin sevelamer , 2018, Diabetes, obesity & metabolism.
[2] Merlin C. Thomas,et al. Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial , 2018, Journal of the American Heart Association.
[3] T. Hansen,et al. Cardiovascular and All-Cause Mortality Risk Associated With Urinary Excretion of 8-oxoGuo, a Biomarker for RNA Oxidation, in Patients With Type 2 Diabetes: A Prospective Cohort Study , 2017, Diabetes Care.
[4] C. Torp‐Pedersen,et al. Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials , 2017, British journal of clinical pharmacology.
[5] B. Staels,et al. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD. , 2017 .
[6] Florence March,et al. 2016 , 2016, Affair of the Heart.
[7] T. Henriksen,et al. Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial , 2016, Redox biology.
[8] Jianping Cai,et al. Elevated Levels of Urinary Markers of Oxidative DNA and RNA Damage in Type 2 Diabetes with Complications , 2015, Oxidative medicine and cellular longevity.
[9] A. Rosengren,et al. Excess Mortality among Persons with Type 2 Diabetes. , 2015, The New England journal of medicine.
[10] M. Portero-Otín,et al. Dietary advanced glycation end products and their role in health and disease. , 2015, Advances in nutrition.
[11] M. Woodward,et al. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[12] T. Vilsbøll,et al. Sevelamer in a diabetologist's perspective: a phosphate‐binding resin with glucose‐lowering potential , 2015, Diabetes, obesity & metabolism.
[13] H. Sies,et al. Oxidative stress: a concept in redox biology and medicine , 2015, Redox biology.
[14] Pietro Ghezzi,et al. Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal , 2014, Proceedings of the National Academy of Sciences.
[15] P. Nielsen,et al. Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. , 2014, Biochimica et biophysica acta.
[16] L. Liaudet,et al. The role of oxidative stress during inflammatory processes , 2013, Biological chemistry.
[17] P. Bork,et al. Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.
[18] Fredrik H. Karlsson,et al. Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.
[19] A. Tjønneland,et al. Association between 8-oxo-7,8-dihydro-2′-deoxyguanosine Excretion and Risk of Postmenopausal Breast Cancer: Nested Case–Control Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[20] T. Henriksen,et al. Association Between Urinary Markers of Nucleic Acid Oxidation and Mortality in Type 2 Diabetes , 2013, Diabetes Care.
[21] M. Woodward,et al. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[22] P. Nielsen,et al. RNA modifications by oxidation: a novel disease mechanism? , 2012, Free radical biology & medicine.
[23] T. Henriksen,et al. Assays for urinary biomarkers of oxidatively damaged nucleic acids , 2012, Free radical research.
[24] E. S. Stovgaard,et al. Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients , 2011, Diabetes Care.
[25] J. Navarro-González,et al. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[26] F. Kuipers,et al. Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism , 2010, Hepatology.
[27] R. Pecoits-Filho,et al. Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia , 2010, Blood Purification.
[28] M. Budoff,et al. Effects of Sevelamer and Calcium-Based Phosphate Binders on Lipid and Inflammatory Markers in Hemodialysis Patients , 2007, American Journal of Nephrology.
[29] L. Ferrucci,et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[30] J. Morillas-Ruiz,et al. The effects of an antioxidant-supplemented beverage on exercise-induced oxidative stress: results from a placebo-controlled double-blind study in cyclists , 2005, European Journal of Applied Physiology.
[31] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[32] P. Raggi,et al. Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. , 2005, American heart journal.
[33] Jingwen,et al. Oxidative Stress Mediates Tumor Necrosis Factor-α–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes , 2003 .
[34] A. Takeshita,et al. Oxidative Stress Mediates Tumor Necrosis Factor-&agr;–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes , 2003, Circulation.
[35] Qiuwei Xu,et al. Bile acid binding to sevelamer HCl. , 2002, Kidney international.
[36] S. Moestrup,et al. Characterization of an enzyme-linked immunosorbent assay for soluble CD163 , 2002, Scandinavian journal of clinical and laboratory investigation.
[37] G. FitzGerald,et al. Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo * , 1999, The Journal of Biological Chemistry.
[38] R. Ramsdell. Renagel: a new and different phosphate binder. , 1999, ANNA journal.
[39] S. Loft,et al. Oxidative DNA damage after transplantation of the liver and small intestine in pigs. , 1995, Transplantation.
[40] C. E. Becker. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. , 1984, JAMA.
[41] M. Trauner,et al. Bile acids in regulation of inflammation and immunity: friend or foe? , 2016, Clinical and experimental rheumatology.
[42] S. Raimondo,et al. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome. , 2016, Clinical and experimental rheumatology.
[43] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[44] A. Nagano,et al. Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis. , 2008, Clinical and experimental rheumatology.
[45] The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.